Member Info for Timster

He said omega and mologic then quoted the government announcement detailing omega and GAD. Who owns GAD?

Who has given up GAD capacity to Avacata?

Sounds like good news for Avacta to me

Avacta

Back at Avacta again

Meanwhile back at Avacta

After rereading the RNS you could almost come to the conclusion that the only test mologic are developing is now Avacta's

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a commercial partnership with Mologic Ltd ("Mologic") to accelerate to market Avacta's AffiDX™ SARS-CoV-2 lateral flow rapid antigen test. Avacta will also support antigen testing in low and middle income countries[1] by providing access to Avacta's spike antigen test through Mologic.

The partnership also immediately provides Avacta with additional manufacturing capacity through Mologic and its partners including Global Access Diagnostics (GAD), in addition to the scaled-up manufacturing capacity being built with BBI and Abingdon Health. Combined, these manufacturing partnerships will deliver several millions of tests per month, and potentially much higher with further investment. Avacta is also continuing its discussions with other manufacturers in the UK and overseas in order to access additional capacity to meet demand.



Clinical evaluation of the lateral flow test is currently being carried out at a hospital in mainland Europe and the Company will shortly initiate further clinical validation studies in the UK and abroad.

Question odx have been awarded 4.6% of the 8 billion tender (if its the same tender)
How much do you think the test developer will get? You know the company that puts the work in with thier amazing affimer tech to get a test that works.

The same affimer tech that already had numerous royalty deals in place and could easily see it licensed around the world.

Honoured, many thanks

Just the ticket for implementing ISO processes

Does this board appear concerned?? Been talking about yacht names most of the day.
I don't think the wanna be "Concerned " holders will worry anyone.

Fantastic attempts though! Just ask yiurself why anyone would start a post " I'm a massive holder but.... "

Good point! They must know something, I'm selling first thing!!! Run for the hills

Very s****y, Sir Al enter stage left

Funny if the bulk of buying today though was because someone got wind of an RNS lodged and that was it ....

I give up.....

That's the dilution we were all fearing ;)

Catch up hector that was early morning conspiracy:)

It is strange I agree but it seems even though there is a consortium each part has thier own distinct contract when they seem to be starting with the lower awards first.

@doorstop 2-3 weeks from the business update 24th Feb

2-3 weeks ago

Another all time high recorded, what's your chart saying wyndrum?

What a great start to the week

Professor Chris Molloy, Chair UK Rapid Antigen Test Consortium, said:

The consortium has been harnessing the power of the UK Diagnostics industry since summer 2020 to significantly contribute to the national effort to ramp up and expand rapid regular testing programmes. We believe, these programmes, alongside vaccine roll-out, will be key for getting people back to work, education and friends and family.

We have increased manufacturing capacity tenfold, and our member’s tests continue to be validated and marketed. We have also started a digital arm comprised of digital solution providers to work with HMG and regulators on new technologies and standards moving forwards.

Numerous bilateral deals have also been agreed between members as a result of industry coming together with intense purpose and leaving competition at the door in order to prioritise the generation of new UK tests and manufacture them at a scale never considered possible.

We would like to take the time now to thank all those suppliers and manufacturers who have contributed their time and resources to this national effort. Our work here lays a strong foundation for how the diagnostics industry as a whole will flourish in the UK to improve our healthcare in the future.